Study,PMID,Species,Phenotype,WT_Mean,KO_Mean,SD,N,Direction,Endpoint,Cohen_d,SE,Weight_fixed
Vaughan et al. 2000,10636155,Mouse,Cardiac fibrosis,24.2,31.1,2.8,30,beneficial,Myocardial collagen content (months survival surrogate),2.4642857142857153,0.41396673921653965,5.835379469059859
Eren et al. 2014,25237099,Mouse,Senescence,3.8,1.4,0.9,25,beneficial,Fibrosis severity score,-2.6666666666666665,0.4776485613378817,4.383116883116884
Erickson et al. 2017,28138559,Mouse,Lifespan,26.3,33.4,3.2,40,beneficial,Median lifespan (months),2.218749999999999,0.33632347757852527,8.840679166758907
Khan et al. 2017,28768707,Mouse,Adipose fibrosis,42.5,18.2,8.1,18,beneficial,Percent fibrotic area,-3.0,0.6130391451319013,2.660869565217391
Placencio et al. 2015,25686606,Mouse,Prostate fibrosis,35.2,12.8,6.3,22,beneficial,Collagen content (µg/mg tissue),-3.555555555555556,0.6260259603399959,2.5516159825446607
Sawdey et al. 1993,8384393,Mouse,Thrombosis latency,65.0,85.0,12.0,20,beneficial,Time to vessel occlusion (minutes),1.6666666666666667,0.41605217846404596,5.777027027027027
Ghosh et al. 2013,23897865,Human fibroblasts,Cellular senescence,68.0,32.0,9.5,15,beneficial,% SA-β-gal positive cells,-3.789473684210526,0.8038621980489262,1.547521842083776
Kortlever et al. 2006,16505382,Mouse,Tumor senescence,28.0,15.0,5.2,16,beneficial,% Ki67+ proliferating cells,-2.5,0.5773502691896258,2.999999999999999
